Dengue: 16 more die

Sixteen more deaths were reported from dengue in 24 hours till Wednesday morning, raising the fatalities from the mosquito-borne disease in Bangladesh to 1046 this year, reports UNB.
During the period, 2,564 more patients were hospitalised with the viral fever, according to the DGHS.
Of the new patients, 720 were admitted to hospitals in Dhaka and the rest outside the capital -- indicating a worsening situation across the country, DGHS said.
A total of 9,284 dengue patients, including 2,945 in the capital, are now receiving treatment at hospitals across the country.
So far, the DGHS has recorded 214,247 dengue cases and 203,917 recoveries this year.
September has so far been the deadliest month for the dengue outbreak this year with 396 fatalities and 79,598 cases, according to DGHS data Meanwhile, the Directorate General of Health Services (DGHS) has sought the advice of the National Immunization Technical Advisory Group (NITAG) on the use of dengue vaccine in the country.
Decision will be taken on the use of the vaccine only after getting the recommendation of the committee, said DGHS Additional Director General (Planning and Development) Prof Ahmedul Kabir at a virtual press briefing on Wednesday.
"Recently, the World Health Organization (WHO) approved the use of the 'Qdenga' vaccine. However, they have also given an age limit condition. This vaccine is nothing new. WHO's advice is that this vaccine can be used. However, just because it (WHO) has cleared it, it cannot be said that it is an ideal vaccine," said Ahmedul.
"In addition to 'Qdenga', there is another dengue vaccine called 'Dengvaxia'. However, it is not possible use it without screening. This vaccine is effective against only one type of dengue. This vaccine is not safe for those who have not been infected with dengue before. In addition, children under the age of nine are not eligible for this vaccine," he also said.